InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Baumal Caroline, Chief Medical Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 11 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €447k. Activity tracked since 3 January 2023. The latest transaction was filed on 29 April 2026 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Baumal Caroline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
86,525 股Common StockSEC:0001193125-26-224577:0
900 股0Common StockSEC:0001492422-26-000105:0
2,797 股@ US$21.765411.7% 占其流量Common StockSEC:0001492422-26-000061:0
1,882 股@ US$19.79297.2% 占其流量Common StockSEC:0001492422-26-000045:0
3,020 股@ US$25.528714.7% 占其流量Common StockSEC:0001492422-26-000016:0
1,853 股@ US$29.958218.1% 占其流量Common StockSEC:0001127602-25-001612:0
39,594 股0Common StockSEC:0001127602-25-001612:1
2,816 股@ US$33.81231.1% 占其流量Common StockSEC:0001127602-25-001011:0
25,445 股0Common StockSEC:0001127602-24-001432:0
2,751 股@ US$60.053450.8% 占其流量Common StockSEC:0001127602-24-000962:0
35,549 股0Common StockSEC:0001127602-23-001003:0
11 条申报中的 11 条
About Baumal Caroline
Caroline Baumal is the Chief Medical Officer at Apellis Pharmaceuticals, Inc. In this role, she is responsible for the medical and clinical aspects of the company's products. Her medical expertise is essential to ensure the safety and efficacy of the treatments developed by Apellis.
